Propofol for Supreme LMA Insertion With and Without Remifentanil

NCT01974648 ↗

Phase 4 Completed 59 enrolled Hospital General Universitario Gregorio Marañon Ministry of Health, Spain · collab

RandomizedParallel-groupTriple-blind

Summary

The aims of this study were to determine the clinically required concentration of propofol for LMA Supreme insertion, and to examine to what extent remifentanil reduces the dose of propofol and improves conditions for it's insertion.

Timeline

Start: 2012-05
Primary completion: 2013-06
Completion: 2013-06

Publications

Zaballos M, Bastida E, Agusti S, Portas M, Jimenez C, Lopez-Gil M. Effect-site concentration of propofol required for LMA-Supreme insertion with and without remifentanil: a randomized controlled trial. BMC Anesthesiol. 2015 Oct 6;15:131. doi: 10.1186/s12871-015-0115-8.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Propofol	Small molecule	—	—
Subject	Remifentanil	Small molecule	—	—

Indications

No indication recorded.